Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App





AI-Based Multi-Modal COVID-19 Risk Score Improves Severity Prediction of Hospitalized COVID-19 Patients

By HospiMedica International staff writers
Posted on 29 Jan 2021
A machine learning model, trained on multimodal data sets that include CT scans of the lungs, is plug and play and able to predict the severity of a COVID-19 patient's disease prognosis with a performance that surpasses all other currently published score benchmarks.

The AI-Severity Score has been developed by Owkin (New York, NY, USA) to help identify hospitalized COVID-19 patients at risk for severe deterioration. More...
Risk scores for identifying predictors of disease severity combine several factors including age, sex, and comorbidities. Some risk scores also include additional markers of severity such as the dyspnea symptom, clinical examination variables such as low oxygen saturation and elevated respiratory rate, as well as biological factors reflecting multi-organ failures. Beyond clinical and biological variables, CT scans also contain prognostic information, as the degree of pulmonary inflammation is associated with clinical symptoms, and the amount of lung abnormality is associated with severe evolution. However, the extent to which CT scans at patient admission add prognostic information beyond what can be inferred from clinical and biological data is unresolved.

Owkin scientists conducted a study to integrate clinical, biological, and radiological data to predict the outcome of hospitalized patients. By processing CT scan images with a deep learning model and by using a radiologist report that contains a semi-quantitative description of CT scans, the team evaluated the additional amount of information brought by CT scans. Owkin scientists collected 58 clinical and biological variables, and chest CT scan data, from 1003 coronavirus-infected patients. The team trained a deep learning model based on CT scans to predict severity and then constructed the multimodal AI-severity score that includes five clinical and biological variables (age, sex, oxygenation, urea, platelet) in addition to the deep learning model. Their study showed that neural network analysis of CT scans brings unique prognosis information, although it is correlated with other markers of severity (oxygenation, LDH, and CRP) explaining the measurable but limited 0.03 increase of AUC obtained when adding CT-scan information to clinical variables. The scientists found that when comparing AI severity with 11 existing severity scores, the prognosis performance improved significantly, suggesting that AI severity can rapidly become a reference scoring approach.

Related Links:
Owkin


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Mobile X-Ray System
K4W
Mammo DR Retrofit Solution
DR Retrofit Mammography
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.